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Abstract
Background: Patients with type 2 diabetes (DM) have a higher risk of developing pulmonary tuberculosis (PTB); moreover,
DM co-morbidity in PTB is associated with poor PTB treatment outcomes. Community based prevalence data on DM and
prediabetes (pre-DM) among TB patients is lacking, particularly from the developing world. Therefore we conducted a
prospective study to investigate the prevalence of DM and pre-DM and evaluated the risk factors for the presence of DM
among newly detected PTB patients in rural areas of China.
Methods and Findings: In a prospective community based study carried out from 2010 to 2012, a representative sample of
6382 newly detected PTB patients from 7 TB clinics in Linyi were tested for DM. A population of 6674 non-TB controls from
the same community was similarly tested as well. The prevalence of DM in TB patients (6.3%) was higher than that in non-TB
controls (4.7%, p,0.05). PTB patients had a higher odds of DM than non-TB controls (adjusted OR 3.17, 95% CI 1.14–8.84).
The prevalence of DM increased with age and was significantly higher in TB patients in the age categories above 30 years
(p,0.05). Among TB patients, those with normal weight (BMI 18.5–23.9) had the lowest prevalence of DM (5.8%). Increasing
age, family history of DM, positive sputum smear, cavity on chest X-ray and higher yearly income ($10000 RMB yuan) were
positively associated and frequent outdoor activity was negatively associated with DM in PTB patients.
Conclusions: The prevalence of DM in PTB patients was higher than in non-TB controls with a 3 fold higher adjusted odds
ratio of having DM. Given the increasing DM prevalence and still high burden of TB in China, this association may represent
a new public health challenge concerning the prevention and treatment of both diseases.
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Introduction
The association between diabetes mellitus (DM) and tubercu-
losis (TB) has been recognised for centuries. DM was a well-known
risk factor for TB [1], but this association was nearly forgotten
after the advent of widely available treatment for both diseases.
With the current global increase in DM largely driven by
increasing prevalence in the developing world, the DM population
is anticipated to reach 552 million by 2030 [2] and the link is re-
emerging. The co-morbidity of DM and TB represents a double
burden with significant public health implications as recently
recognised by several authors [3,4]. In developing countries such
as India, China, Bangladesh, Indonesia and Brazil, where TB is
still highly endemic [5], the double burden and interaction of DM
and TB will be more ominous. China accounts for nearly 17% of
the world’s TB burden, with an estimated 1.5 million new cases
and approximately 270,000 deaths each year. In the meantime,
the country has also witnessed an escalating epidemic of DM [2] as
the consequence of industrialization, urbanization, increase in life
expectancy, and changes in lifestyle in recent years. It was recently
reported that the age standardised prevalence of DM and
impaired glucose tolerance (IGT) reached to 9.7% and 15.5%
respectively in China [6].
Jeon CY et al carried out a large meta analysis and discovered
that DM patients were 3.1 times (95% CI 2.27–4.26) more likely to
have TB than non-diabetic controls [7] and it has been estimated
that the TB risk attributable to DM was between 15% and 25%
[8,9]. Two large scale longitudinal cohort studies from Korea and
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UK have shown similar findings with risk ratios of 3.47 (95% CI
2.98–4.03) and 3.80 (95% CI 2.30–6.10) [10,11]. The mechanism
behind the association between TB and DM is not fully
understood but studies suggest that DM depresses the immune
response through effects on macrophage and lymphocyte function,
which in turn facilitates active TB disease. Conversely, it is also
possible that TB can induce glucose intolerance and also
deteriorate glycemic control in subjects with DM [12].
However, only a few studies have reported on screening for DM
in TB patients. A wide range of DM prevalence among TB
patients (1.9% to 39%) has been reported and most of the studies
are based on secondary data analysis, self-reported DM, or have a
small sample size [7,10,13]. Gaining a deeper understanding of the
differences between TB patients with and without DM is urgently
needed to prevent the co-morbidity and to improve the prognosis
of the patients with DM and TB. Therefore, we initiated this large
scale prospective epidemiologic study using primary data to
identify the current prevalence of DM and pre-DM in newly-
diagnosed PTB patients together with non-TB controls from the
same community. Also, the odds ratios for DM among TB patients
were analysed in order to get the clues to the early detection of
DM in TB patients, and to figure out DM patient with what
characteristics should be given priority to the prevention of TB.
Methods
Ethics Approval
This study was carried out in accordance with requirements
documented in the Declaration of Helsinki. Ethics approval was
obtained from the medical ethics committee of Qingdao Disease
Prevention and Control Centre, Qingdao, People’s Republic of
China. All participants were fully informed and gave their written
informed consent. This trial is registered in the Chinese Clinical
Trial Registry (No. ChiCTR-OCC-10000994, URL: http://
www.chictr.org/cn/proj/show.aspx?proj = 411).
Study Population
The study population was selected from Linyi rural area,
Shandong province in North China. Seven TB clinics were
randomly selected for this study including Yishui, Yinan, Lanshan,
Cangshan, Tancheng, Feixian and Pingyi. Each TB clinic had a
defined catchment area comprising approximately 0.9 million
inhabitants. The diagnosis of PTB was made within the existing
TB prevention and control system in China, in which clinical
manifestations, sputum smear microscopy and chest radiography
were the central component. Suspected PTB person was
investigated by sputum smear examination. The patient was
diagnosed as smear-positive PTB if sputum specimens were smear
positive; if sputum smears were negative and chest radiograph was
compatible with active PTB, the patient was diagnosed as smear-
negative PTB after discussion by clinical and radiographic doctors
[9]. All adult ($18 years) newly-diagnosed PTB patients who
registered for Directly Observed Treatment, Short Course
(DOTS) in these TB clinics from September 2010 to December
2012 were included. HIV-positive patients were excluded because
of the influence of antiretroviral therapy on insulin resistance as
were subjects with type 1 diabetes.
A sample size of 7000 was calculated, assuming a prevalence of
DM as 6.7% amongst the TB subjects as reported in the literature
[14], considering non-response rate of 20% [15]. We adjusted it to
6200 because of better compliance of the participants observed in
the pilot study than expected (modifying non-response rate to
10%). For estimating DM and pre-DM prevalences amongst the
non-TB cohort, cluster random sampling was used to recruit
subjects from the same communities as the TB cases.
Diagnosis of DM and pre-DM was based on WHO criteria for
the classification of glucose tolerance based on fasting plasma
glucose (FPG) [16]. After an overnight fast, venous blood of each
participant was collected. Glucose oxidase method was used to
estimate FPG level. Those with FPG$6.1 mmol/L were referred
to DM clinics for diagnostic confirmation with a second FPG test.
Those with FPG level in the range of 6.1 mmol/L to 6.9 mmol/L
were screened as pre-DM; those with FPG level $7.0 mmol/L
were screened as DM. Lipid indexes including total cholesterol,
triglyceride and HDLC were estimated by enzymatic procedure.
Anthropometric measurements including height and weight by
standard procedure were measured by trained investigators. Body
mass index (BMI, kg/m2) was calculated by using the formula:
BMI=Weight (kg)/Height2 (m2). Underweight, normal weight,
overweight, and obesity were defined by using the modified
criteria for Chinese population [17]. The BMI cut-off value for
underweight (severe underweight, moderate underweight, mild
underweight), normal weight, overweight, and obesity was
,18.5 kg/m2 (,16 kg/m2, 16,16.9 kg/m2, 17,18.4 kg/m2),
18.5,23.9, 24.0,27.9 kg/m2 and $28.0 kg/m2, respectively.
Two blood pressure measurements were taken using sphygmo-
manometer with the subject in sitting posture, and the average of
the two readings was recorded.
A structured questionnaire was administered to obtain infor-
mation regarding socio-demographics, personal and family disease
history, and lifestyle risk factors including smoking, alcohol
consumption, educational level, outdoor activity, yearly income
and marital status. The interviews were conducted by trained local
TB workers in order to assure compliance and quality of the data
collected.
Data Management and Quality Control
Double data entry was carried out, and then a computer based
error detection system was used to check the consistency of data.
In case of inconsistency, the original questionnaire was checked
and the error corrected via a re-entry. During the investigation,
different methods of quality control including inter-lab comparison
of glucose measurement were carried out.
Statistical Analysis
The study design followed STROBE Guidelines [18]. SPSS
version 19.0 was used for statistical analysis. Characteristics of TB
and non-TB controls were compared and the study characteristic
of TB patients by diabetes status including normoglycemia (Non-
DM), prediabetes (Pre-DM), and diabetes (DM) were analyzed.
Mean and standard deviation for continuous variables and
proportions for categorical variables are reported. Independent
sample t test and ANOVA were used to test continuous variables.
Chi-square or Fisher’s exact test was used to compare categorical
variables. Kruskal-Wallis H test was used to compare ranked
variable. Two multinomial logistic regression analyses were
performed. The variables for inclusion in the multivariate model
were chosen based on plausibility and variables with p values of
,0.1 in univariate analysis were entered into the multivariate
analysis. One multivariate logistic analysis was to examine the
association between PTB and DM and pre-DM and to calculate
odd ratios and 95% confidence intervals. The dependent variable
was either DM or pre-DM, the independent variables being
suffering from active PTB and we examined the following
covariates for the effect modification or confounding: age [(years)
(categorized in 4 units: ,30, 30–39, 40–49, $50], sex, BMI [(kg/
m2) (categorized as ,18.5, 18.5–23.9, $24.0)]), yearly income
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[(RMB yuan) (categorized as,2000, 2000–9999, $10000], family
history of DM, smoking, alcohol consumption, outdoor activity,
education level and marital status. The other logistic regression
analysis was performed to qualify the odds of having DM and pre-
DM in active PTB patients, the dependent variable being either
DM or pre-DM and the independent variables being the same as
the first model without active TB and with PTB profile including
positive sputum smear, cavity and involved lung field on chest
radiograph. The entry probability was p#0.05 and the removal
probability was p.0.10. All variables were checked for collinearity
in both models. The model fit was significant for both multinomial
logistic regression analyses (x2 = 285.6 and 372.8, respectively,
p,0.001) and the fit was good (x2 = 1093.47 and 1067.52,
respectively, p.0.05). A p value of ,0.05 was considered
statistically significant.
Results
The details on the total number of eligible PTB patients, those
who gave written consent to undergo screening of DM and those
included in the final analysis are illustrated in a flow chart
(Figure 1). A total of 8410 patients of $18 years of age were
registered for TB treatment in the above 7 TB clinics in the study
period. Finally, 6902 PTB patients completed the study. After the
exclusion of 520 persons for whom demographic information or
fasting glucose levels were missing, 6382 patients (4627 men and
1715 women) were included in the final analysis. The recorded
response rate was 92.5%.
General Characteristics
The demographic and anthropometric information of the TB
and non-TB cohort is detailed in Table 1.
Data from 6382 TB patients and 6675 non-TB controls was
available for analysis. The mean age of the PTB patients was
50.4618.6 and of the non-TB controls 50.8616.4 (p.0.05).
There was a significant sex difference between TB and non-TB
(p,0.001). Mean BMI of non-TB cohort was significantly higher
than that of the TB cohort (p,0.001). Systolic blood pressure and
diastolic blood pressure were higher in non-TB cohort compared
to TB cohort (p,0.001). Plasma glucose level was higher in TB
patients compared to non-TB controls (p,0.001). Smoking was
more common in TB patients than in non-TB controls (p,0.001),
while alcohol consumption was higher in non-TB (p,0.001).
Relationship Between PTB and DM
Details of the DM and pre-DM prevalence in TB patients and
non-TB controls are shown in Figure 2. Based on FPG, out of
6382 TB patients, 403 (6.3%) had DM; while out of 6675 non-TB
controls, 313 (4.7%) had DM. The prevalence of DM in TB
patients was significantly higher than in non-TB controls (p,0.05).
In males, the prevalence of DM was 52% higher in TB than in
non-TB (p,0.05). Taking into account possible confounding
factors such as age, sex, BMI, family history of DM, education
level, smoking, alcohol consumption, outdoor activity and marital
status, we found that PTB patients had 3.17 times higher odds of
having DM compared with non-TB control (Table 2).
The prevalence of DM increased with increasing age and was
significantly higher in the TB groups than in the non-TB groups
except for the age subgroup ,30. The same tendency existed for
pre-DM but the difference was only significant in the age subgroup
of 30,39 (Figure 2).
Among BMI subgroups in TB patients, those with normal BMI
(18.5–23.9) had the lowest prevalence of DM (5.8%), while the
prevalence of DM in overweight and obese cases (BMI$24) was
the highest (7.7%). The greatest difference (2.6 fold) in DM
prevalence between TB and non-TB was observed in the
underweight group (p,0.05) (Figure 2).
DM was newly detected in 177 (43.9%) PTB patients and in 136
(43.5%) non-TB controls, respectively. In general, patients with
previously diagnosed DM had higher fasting plasma glucose levels
than did those with newly-diagnosed DM. 10.3% of previously
known DM cases had their blood glucose level tested regularly.
Figure 1. Flowchart of the pulmonary tuberculosis patients in the study, Linyi, 2010–2012. The details on the total number of eligible
participants, those who have given written consent to undergo screening of DM and the patients included in the final analysis are illustrated in
Figure 1. There were 8410 newly detected pulmonary tuberculosis patients in total study period. Finally, 6382 patients were included in the final
analysis.
doi:10.1371/journal.pone.0082660.g001
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The prevalence of pre-DM in TB patients and non-TB controls
was 7.4% and 6.6%, respectively, all previously undiagnosed.
Characteristics of TB Patients with DM or Pre-DM
Table 3 shows the comparison of the study characteristics of
PTB patients with Non-DM, Pre-DM, and DM.
Among PTB cases (6382), 403 patients had DM and 470 had
pre-DM. PTB patients with DM and pre-DM were older than the
subjects with normoglycemia (57.81, 57.11 vs 49.29, p,0.001).
PTB patients with DM had a higher systolic and diastolic blood
pressure in comparison with patients with normoglycemia and
pre-DM (p= 0.024, 0.017, respectively). Triglyceride and total
cholesterol were higher compared with patients with normogly-
cemia (p = 0.024, ,0.001, respectively).
Profile of PTB also showed significant difference. A higher
proportion of PTB patients with DM were smear positive (61.6%)
compared to those with normoglycaemia (46.8%). A small
proportion of patients were categorised as PTB relapse, and
patients with DM had the highest relapse rate (p,0.001).
Odds Ratios for DM and Pre-DM among PTB Patients by
Multivariate Risk Assessment
In the multivariate logistic regression models, increasing age,
family history of DM, positive sputum smear, cavity on chest X-
ray and higher yearly income ($10000 RMB yuan) were
significantly associated with an increased odds of DM in TB
patients. Underweight had a borderline significant association with
DM compared with normal weight (OR=1.30, p = 0.082).
Frequent outdoor activity was negatively associated with DM
odds. Age category of $50 years had the highest odds ratio of
13.20 (p,0.001), followed by age category of 40, years and
family history of DM with OR 9.46, 5.85 respectively. Associations
were not observed for sex, education, smoking, alcohol consump-
tion, marital status and involved lung field on chest X-ray
(Table 4).
As to having pre-DM, age, family history of DM, overweight,
obesity and underweight were positively associated, and frequent
outdoor activity was also negatively associated with pre-DM odds.
Discussion
The present study shows that the prevalence of DM based on
FPG values was higher in the PTB (6.3%) patients than in the non-
TB (4.7%) controls, and PTB patients had 3.17 times the odds of
having DM as non-TB subjects, when adjusted for possible
confounding factors.
Our study was designed to discover the prevalence of DM and
pre-DM in TB patients and estimate the odds ratios. The strength
of this study is its community based setting. To avoid selection
bias, we chose community based TB clinics instead of TB
hospitals, which means the prevalence and odds ratios can be
regarded as representative for the general population. Also, the
large sample size allowed us to provide relatively precise estimates
of current prevalence of DM in TB. To accurately define DM, we
used primary data collected from newly-diagnosed PTB patients
and also in a non-TB control group. In other related studies, either
the DM prevalence in non-TB was not reported or the prevalence
being calculated from secondary data with inherent biases [19,20].
Only a few reports concerning the prevalence of DM in active TB
patients in China are available until now. Zhang Q et al carried
out a retrospective analysis in Shanghai pulmonary hospital from
2008–2009 and discovered 9.2% TB patients were complicated by
DM [21]. Also from Shanghai, in 1997, Lin S et al reported 4.86%
prevalence of DM in TB cases, DM tending to be more prevalent
among TB patients in urban area and in older patients [22]. Liang
Li et al reported a prevalence of 12.4% in a study based in
different parts of China, primarily based on hospital data using
FPG [23]. Until now, there were no community based data on the
prevalence of DM among sufficiently large samples of TB patients
as well as comparative data from non-TB controls from the same
community collected in the same time period.
It has been reported that PTB may induce temporary
hyperglycemia, which resolves with treatment [14]. Thus, over-
diagnosis might take place if tested for glucose prior to initiation of
TB treatment. Most of our study subjects were screened for DM
2–3 weeks after the initiation of TB treatment.
We found that the associated factors for having DM were
basically the same for PTB patients as for the general population.
Increasing age, family history of DM and high income were
positive associated factors for DM in PTB patients. For BMI the
pattern looks somewhat different. The World Health Organiza-
tion’s (WHO) ‘‘standard’’ definition for underweight, overweight,
and obesity by BMI are #18.5 kg/m2, 25.0 to 29.9 kg/m2, and
$30.0 kg/m2, respectively [24]. But in China as in other parts of





Male, n(%) 4631(72.90) 3712(55.61) ,0.001
Age 50.41618.63 50.77616.40 0.242
BMI 20.9162.76 22.5262.99 ,0.001
Sbp 119.69611.43 123.95615.00 ,0.001
Dbp 76.7067.70 79.3169.80 ,0.001
Plasma glucose 5.3961.88 5.1561.20 ,0.001
Hemoglobin 131.89617.25 131.07643.48 0.610
Total cholesterol 4.3961.09 4.6961.20 ,0.001
HDLC 1.4660.60 1.6360.82 ,0.001
Triglyceride 1.2061.11 1.3160.94 0.884
DM Family history, n (%) 695(11.4) 765(12.6) ,0.001
Smoking, n (%) 900(14.1) 379(5.7) ,0.001
Alcohol consumption, n (%) 414(6.5) 753 (11.6) ,0.001
Yearly income, n(%)




Married 4694(79.4) 5419(87.8) ,0.001
Single/widowed/divorced 1221(20.6) 754(12.2)
Educational status, n(%)
illiteracy 1625(27.4) 1553(25.2) ,0.001
primary or middle school 3558(59.9) 3300(53.5)
high school or higher 758(12.8) 1312(21.3)
Outdoor activity, n (%)
.2 hours/d 3779(63.6) 4041(67.5) ,0.001
#2 hours/d 1863(31.4) 1644(27.5)
None 300(5.0) 302(5.0)
doi:10.1371/journal.pone.0082660.t001
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Asia, a modified criteria is more appropriate to forecast the risk of
DM, dyslipidemia and the related diseases [17] and we used this
criteria for the cut-off value. The severe underweight and
moderate underweight categories only account for 3.4% and
3.7% of the TB patients respectively in our study, so we combined
them with mild underweight accounting for totally 17.7%
underweight patients in our study. Similarly, obesity only accounts
for 0.7% in the PTB cases and we combined it with the overweight
subgroup, together accounting for 13.9% overweight and obese
PTB cases. Although the average BMI in PTB patients with DM,
pre-DM and normoglycemia did not show obvious difference, in
logistic regression analysis, underweight (BMI,18.5 kg/m2)
showed a significant association with pre-DM and borderline
significance for DM. This finding was more or less similar to the
study carried out in Tanzania [25] that reported severe
underweight (BMI,16 kg/m2) among male TB patients was
associated with DM (OR 2.52, p = 0.004). Underweight is a risk
factor for many chronic diseases such as respiratory diseases,
Figure 2. The prevalence of diabetes and prediabetes in TB and non-TB. The overall prevalence of diabetes and prediabetes in TB and non-
TB was shown in Figure 2. Also, the sex, age (,30, 30,39, 40,49, $50) and BMI (,18.5, 18.5,23.9, $24.0) stratified prevalences were shown. The
prevalence of diabetes in PTB patients was 6.3%, which was significantly higher than in non-TB controls (4.7%). The prevalence of diabetes increased
with increasing age and was significantly higher in the TB than in the non-TB groups except for the age group ,30. Among BMI subgroups in TB
patients, normal weight patients with a body mass index of 18.5–23.9 had the lowest prevalence of DM (5.8%), while the prevalence in overweight
and obese cases (BMI$24) was the highest. TB: pulmonary tuberculosis patients, non-TB: non tuberculosis controls.
doi:10.1371/journal.pone.0082660.g002
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osteoporosis, as well as DM [26]. Like in the general population,
TB patients with overweight and obesity were at 1.44 fold odds of
having pre-DM compared to normal weight patients. But the
association was not significant for DM. However, the proportion
of overweight and obesity in patients with DM (17.0%) was higher
than in patients without DM (13.4%). The association for BMI in
the setting of co-morbid DM and TB is complex. While increasing
the risk of DM and pre-DM, overweight and obesity is protective
against TB disease [27]. Weight loss due to poorly controlled DM
and metabolic de-compensation takes away this protection.
Presence of TB increases risk of hyperglycaemia through stress
but by causing weight loss reduces the risk. These interactions may
play out differently in different individuals [28].
The association of positive sputum smear with DM in TB
patients was similar to what has been reported earlier [20,29]. In
our study, patients with DM had the highest rate of positive
sputum smear, which indicates high risk of infectivity and spread
of TB by these patients. Presence of cavities on chest X-rays was
significantly associated with co-morbid DM in our study.
Over half of our DM cases (56.1%) were already diagnosed
previously. This was lower than nearly all DM patients being
aware in the report by Restrepo BI et al [19] and about 75% being
aware of DM in the study by Liang Li et al [23]. This difference
maybe because our study population was primarily from rural
areas where DM awareness and screening are limited. In this
context the importance of strengthening monitoring and control of
DM becomes relevant. In the present study, only 10.3% of
previously known DM cases had their blood glucose level tested
regularly. The need for improving DM care services as well as
health education about the link between TB and DM cannot be
overemphasized, particularly in areas with double burden of the
diseases. Our findings show that the opportunities for preventing
TB among DM patients should receive greater attention by the
health system. DM patients should be aware of their increased risk
of active TB. They should be educated to report to TB clinics in
time when suspicious TB symptoms occur in order to benefit from
having early diagnosis and treatment. Furthermore, underweight
persons with DM should be paid high attention given the observed
positive association in our study.
Table 2. Odds Ratio for diabetes and prediabetes by PTB in Linyi, China, 2010–2012.
Diabetes Prediabetes
Crude OR p Adjusted OR* p Crude OR p Adjusted OR* p
overall 1.38(1.19–1.61) ,0.001 3.17(1.14–8.84) 0.027 1.15(1.01–1.32) 0.041 1.14(0.50–2.57) 0.76
male 1.59(1.35–1.94) ,0.001 3.27(1.06–10.06) 0.039 1.25(1.05–1.48) 0.013 1.09(0.46–2.56) 0.84
*Adjusted for age, BMI, sex, family history of DM, yearly income, education level, smoking, alcohol consumption, outdoor activity, marital status.
doi:10.1371/journal.pone.0082660.t002
Table 3. Study characteristics of TB patients by diabetes status in Linyi, China, 2010–2012.
Characteristics Non-DM Pre-DM DM p value
N 5509 470 403
Male, n(%) 3992(72.5) 341(72.6) 298(73.9) 0.813
Age(years) 49.29618.97 57.11614.72* 57.81614.23* ,0.001
BMI(kg/m2) 20.9062.72 20.8662.97 21.0963.06 0.234
Underweight 866(17.2) 95(21.8)* 77(20.8)* ,0.001
Normal 3504(69.5) 265(60.8)* 231(62.3)*
Overweight and obesity 674(13.4) 76(17.4)* 63(17.0)*
Blood Pressure (mmHg)
Systolic 119.53611.26 119.91611.77 121.62613.07* 0.024
Diastolic 77.5167.70 77.8566.78 78.6168.61* 0.017
Fasting glucose (mmol/l) 4.9460.60 6.4460.26* 10.3064.81*& ,0.001
Haemoglobin (g/L) 131.88616.90 132.30618.99 131.54620.08 0.762
Triglyceride (mmol/l) 1.1961.09 1.2361.47 1.3560.74* 0.024
Total cholesterol (mmol/l) 4.3461.01 4.6161.24* 4.7561.62* ,0.001
HDLC (mmol/l) 1.4460.59 1.6560.74* 1.4760.52& ,0.001
Type of PTB*, n(%)
Smear positive cases 2513 (46.8) 237 (55.3) 198 (61.6)* ,0.001
Smear negative cases 2857 (53.2) 192 (44.7) 123 (38.4)
Relapse, n(%) 247 (4.6) 24 (5.6) 28 (8.8)* ,0.001
Note:
*p,0.05 compared with non-DM group,
&p,0.05 compared with pre-DM group.
doi:10.1371/journal.pone.0082660.t003
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Also, updating the educational curriculum of health profession-
als to increase their awareness of the re-emerging association
between TB and DM is urgently required. We discovered that the
link of TB and DM was not prioritized in the seven TB clinics that
participated in our project, three of which even did not measure
the blood glucose level of the TB patients before we started this
project. Within the framework of the current project, we
implemented health education on the links between TB and
DM for TB patients, health care providers and the lay public, the
results of which will be reported later.
However, our study also has some limitations. First, since
isolated hyperglycemia 2 hours after glucose loading is common
among Asian patients with DM [30], we may have underestimated
the prevalence of DM because an oral glucose tolerance test
(OGTT) was not done for practical reasons. However, the same
level of underestimation will apply for the non-TB group and thus
does not change the relative odds.
In Shanghai Diabetes Study, 48.6% of patients with newly-
diagnosed DM had isolated hyperglycemia 2 hours after glucose
loading [31]. So, the actual prevalence rates of DM and pre-DM
in our study may have been much higher. This may also explain
the difference between our findings and other studies carried out
where dual burden of TB and DM also exists. The prevalence
rates of DM and pre-DM were 25.3% and 24.5% respectively
among TB patients in South India [20].
Another lacuna in our study is that M. tuberculosis (MTB)
infection was not confirmed by sputum culture in a substantial
number of participants in the clinical settings in our study.
However, according to the recent national TB epidemiological
survey in China, positive MTB culture is documented in only
26.4% of the active PTB patients [32], which means that nearly
three quarter of the active PTB may be missed if we would take
the MTB culture result as the gold standard. As with most TB
centres, clinical manifestations, sputum smear microscopy and
chest radiographs were the central component for PTB diagnosis
in our study.
Our study provides further evidence of the links between DM
and TB and the evidence that this interaction is playing out even
in the rural settings in China where the presumed burden of DM
appears low. Our findings indicate the potential benefits of
partially integrating TB and DM prevention and control systems,
and males may benefit the most given the higher prevalence of TB
among them. Given the growing huge burden of DM in China
and the high rate of undetected DM, systematic screening of all
TB patients for DM through the infrastructure for TB control
could serve to improve the early detection of DM, particularly in
developing countries. Liang Li et al indicate that such screening
has the potential of identifying almost 30,000 new cases of DM
each year in China [23]. Follow-up studies are needed to identify
the causal mechanism of the link between TB and DM in the
future.
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Table 4. Multivariate-adjusted odds ratios for diabetes and prediabetes in pulmonary tuberculosis patients.
Significant variables Diabetes OR (95% CI) p value Prediabetes OR(95% CI) p value
Age(years)
,30(reference) – – – –
30, 5.35 (2.47–11.57) ,0.001 3.61 (1.96–6.64) ,0.001
40, 9.46 (4.61–19.43) ,0.001 4.29 (2.40–7.66) ,0.001
$50 13.20 (6.71–25.96) ,0.001 5.74 (3.37–9.76) ,0.001
DM Family history 5.85 (4.44–7.69) ,0.001 1.58 (1.14–2.20) 0.006
BMI
18.5–23.9 (reference) – – – –
,18.5 1.30 (0.97–1.76) 0.082 1.38 (1.05–1.80) 0.019
$24.0 1.08 (0.77–1.53) 0.644 1.44 (1.07–1.93) 0.015
Positive sputum smear 1.61(1.08–2.40) 0.021 1.36 (0.96–1.94) 0.085
Cavity on chest X-ray 1.66(1.07–2.59) 0.025 0.76(0.46–1.26) 0.285
Frequent outdoor activity 0.63 (0.49–0.80) ,0.001 0.72 (0.58–0.89) 0.003
Yearly income(RMB)
,2000 (reference) – – – –
2000–9999 1.34 (0.94–1.92) 0.106 0.87 (0.65–1.16) 0.337
$10000 1.65 (1.09–2.50) 0.017 0.95 (0.67–1.34) 0.768
nonsignificant variables: sex, marital status, smoking, alcohol consumption, educational level, involved lung field.
doi:10.1371/journal.pone.0082660.t004
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